Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Paclitaxel administration & dosage"" wg kryterium: Temat


Tytuł :
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Autorzy :
Coleman, Robert L
Fleming, Gini F
Brady, Mark F
Swisher, Elizabeth M
Steffensen, Karina D
Friedlander, Michael
Okamoto, Aikou
Moore, Kathleen N
Efrat Ben-Baruch, Noa
Werner, Theresa L
Cloven, Noelle G
Oaknin, Ana
DiSilvestro, Paul A
Morgan, Mark A
Nam, Joo-Hyun
Leath, Charles A
Nicum, Shibani
Hagemann, Andrea R
Littell, Ramey D
Cella, David
Baron-Hay, Sally
Garcia-Donas, Jesus
Mizuno, Mika
Bell-McGuinn, Katherine
Sullivan, Danielle M
Bach, Bruce A
Bhattacharya, Sudipta
Ratajczak, Christine K
Ansell, Peter J
Dinh, Minh H
Aghajanian, Carol
Bookman, Michael A
Pokaż więcej
Temat :
Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Benzimidazoles/adverse effects
Carboplatin/administration & dosage
Combined Modality Therapy
Cystadenocarcinoma, Serous/drug therapy
Double-Blind Method
Female
Genes, BRCA1
Genes, BRCA2
Humans
Intention to Treat Analysis
Maintenance Chemotherapy
Middle Aged
Mutation
Ovarian Neoplasms/drug therapy
Paclitaxel/administration & dosage
Poly(ADP-ribose) Polymerase Inhibitors/adverse effects
Progression-Free Survival
Quality of Life
Źródło :
Coleman, R L, Fleming, G F, Brady, M F, Swisher, E M, Steffensen, K D, Friedlander, M, Okamoto, A, Moore, K N, Efrat Ben-Baruch, N, Werner, T L, Cloven, N G, Oaknin, A, DiSilvestro, P A, Morgan, M A, Nam, J-H, Leath, C A, Nicum, S, Hagemann, A R, Littell, R D, Cella, D, Baron-Hay, S, Garcia-Donas, J, Mizuno, M, Bell-McGuinn, K, Sullivan, D M, Bach, B A, Bhattacharya, S, Ratajczak, C K, Ansell, P J, Dinh, M H, Aghajanian, C & Bookman, M A 2019, ' Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer ', The New England Journal of Medicine, vol. 381, no. 25, pp. 2403-2415 . https://doi.org/10.1056/NEJMoa1909707
Tytuł :
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Autorzy :
de Boer, Stephanie M.
Powell, Melanie E.
Mileshkin, Linda
Katsaros, Dionyssios
Bessette, Paul
Haie-Meder, Christine
Ottevanger, Petronella B.
Ledermann, Jonathan A.
Khaw, Pearly
Colombo, Alessandro
Fyles, Anthony
Baron, Marie Helene
Jürgenliemk-Schulz, Ina M.
Kitchener, Henry C.
Nijman, Hans W.
Wilson, Godfrey
Brooks, Susan
Carinelli, Silvestro
Provencher, Diane
Hanzen, Chantal
Lutgens, Ludy C.H.W.
Smit, Vincent T.H.B.M.
Singh, Naveena
Do, Viet
D'Amico, Romerai
Nout, Remi A.
Feeney, Amanda
Verhoeven-Adema, Karen W.
Putter, Hein
Creutzberg, Carien L.
McCormack, Mary
Whitmarsh, Karen
Allerton, Rozenn
Gregory, Deborah
Symonds, Paul
Hoskin, Peter J.
Adusumalli, Madhavi
Anand, Anjana
Wade, Robert
Stewart, Alexandra
Taylor, Wendy
Kruitwagen, Roy F.P.M.
Hollema, Harry
Pras, Elizabeth
Snyers, An
Stalpers, Lukas
Jobsen, Jan J.
Slot, Annerie
Mens, Jan Willem M.
Stam, Tanja C.
Pokaż więcej
Temat :
Carboplatin/administration & dosage
no
Comparative Study
Neoplasm Staging
Cisplatin/administration & dosage
Oncology
Carcinoma, Endometrioid/mortality
Paclitaxel/administration & dosage
Research Support, Non-U.S. Gov't
New Zealand
Neoplasm Grading
Time Factors
Endometrial Neoplasms/mortality
Dose Fractionation, Radiation
Female
Europe
Risk Factors
Chemoradiotherapy, Adjuvant/adverse effects
Aged
Australia
Middle Aged
Treatment Outcome
Clinical Trial, Phase III
Randomized Controlled Trial
Gynecologic Surgical Procedures/adverse effects
Lymph Node Excision
Canada
Multicenter Study
Journal Article
Radiotherapy, Adjuvant
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Humans
Źródło :
PORTEC study group 2018, ' Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3) : final results of an international, open-label, multicentre, randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 3, pp. 295-309 . https://doi.org/10.1016/S1470-2045(18)30079-2
lancet oncology, 19(3), 295 - 309. Lancet Publishing Group
The Lancet Oncology, 19(3), 295. Lancet Publishing Group
Opis pliku :
image/pdf
Tytuł :
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Autorzy :
de Boer, Stephanie M.
Powell, Melanie E.
Mileshkin, Linda
Katsaros, Dionyssios
Bessette, Paul
Haie-Meder, Christine
Ottevanger, Petronella B.
Ledermann, Jonathan A.
Khaw, Pearly
Colombo, Alessandro
Fyles, Anthony
Baron, Marie-Helene
Jurgenliemk-Schulz, Ina M.
Kitchener, Henry C.
Nijman, Hans W.
Wilson, Godfrey
Brooks, Susan
Carinelli, Silvestro
Provencher, Diane
Hanzen, Chantal
Lutgens, Ludy C. H. W.
Smit, Vincent T. H. B. M.
Singh, Naveena
Do, Viet
D'Amico, Romerai
Nout, Remi A.
Feeney, Amanda
Verhoeven-Adema, Karen W.
Putter, Hein
Creutzberg, Carien L.
Pokaż więcej
Temat :
Carboplatin/administration & dosage
Neoplasm Staging
Cisplatin/administration & dosage
GYNECOLOGIC-ONCOLOGY-GROUP
CHEMOTHERAPY
Paclitaxel/administration & dosage
Carcinoma, Endometrioid/mortality
New Zealand
Neoplasm Grading
Time Factors
Endometrial Neoplasms/mortality
CLINICAL-TRIALS
Dose Fractionation, Radiation
Female
Europe
Risk Factors
Chemoradiotherapy, Adjuvant/adverse effects
Aged
Australia
Middle Aged
PROGNOSIS
Treatment Outcome
Article
RECURRENCE
RADIATION-THERAPY
III TRIAL
Gynecologic Surgical Procedures/adverse effects
Lymph Node Excision
CARCINOMA PATIENTS
Canada
QUALITY-OF-LIFE
Radiotherapy, Adjuvant
STAGE-I
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Humans
Źródło :
Lancet oncology, 19(3), 295 - 309. Elsevier Science
Lancet Oncology, 19(3), 295 - 309. ELSEVIER SCIENCE INC
Opis pliku :
application/pdf
Tytuł :
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer:Randomized phase II study
Autorzy :
Han, H. S.
Diéras, V.
Robson, M.
Palácová, M.
Marcom, P. K.
Jager, A.
Bondarenko, I.
Citrin, D.
Campone, M.
Telli, M. L.
Domchek, S. M.
Friedlander, M.
Kaufman, B.
Garber, J. E.
Shparyk, Y.
Chmielowska, E.
Jakobsen, E. H.
Kaklamani, V.
Gradishar, W.
Ratajczak, C. K.
Nickner, C.
Qin, Q.
Qian, J.
Shepherd, S. P.
Isakoff, S. J.
Puhalla, S.
Pokaż więcej
Temat :
Metastatic breast cancer
PARP inhibitors
Platinum
Temozolomide
Single-Blind Method
Humans
Middle Aged
Male
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Temozolomide/administration & dosage
Young Adult
Neoplasm Metastasis
Genes, BRCA2
Germ-Line Mutation
Placebos
Adult
Female
Genes, BRCA1
Breast Neoplasms/drug therapy
Benzimidazoles/administration & dosage
Neoplasm Recurrence, Local/drug therapy
Paclitaxel/administration & dosage
Breast Neoplasms, Male/drug therapy
Carboplatin/administration & dosage
Aged
Źródło :
Han, H S, Diéras, V, Robson, M, Palácová, M, Marcom, P K, Jager, A, Bondarenko, I, Citrin, D, Campone, M, Telli, M L, Domchek, S M, Friedlander, M, Kaufman, B, Garber, J E, Shparyk, Y, Chmielowska, E, Jakobsen, E H, Kaklamani, V, Gradishar, W, Ratajczak, C K, Nickner, C, Qin, Q, Qian, J, Shepherd, S P, Isakoff, S J & Puhalla, S 2018, ' Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer : Randomized phase II study ', Annals of Oncology, vol. 29, no. 1, pp. 154-161 . https://doi.org/10.1093/annonc/mdx505
Tytuł :
Clopidogrel paclitaxel drug-drug interaction:A pharmacoepidemiologic study
Autorzy :
Agergaard, K
Mau-Sørensen, M
Stage, T B
Jørgensen, T L
Hassel, R E
Dahl Steffensen, Karina
Pedersen, J W
Milo, M L H
Poulsen, S H
Pottegård, A
Hallas, J
Brøsen, K
Bergmann, T K
Pokaż więcej
Temat :
Aged
Aspirin/administration & dosage
Clopidogrel
Cytochrome P-450 CYP2C8/metabolism
Dose-Response Relationship, Drug
Drug Interactions
Female
Humans
Liver/metabolism
Male
Middle Aged
Paclitaxel/administration & dosage
Peripheral Nervous System Diseases/chemically induced
Pharmacoepidemiology
Platelet Aggregation Inhibitors/administration & dosage
Retrospective Studies
Severity of Illness Index
Ticlopidine/administration & dosage
Źródło :
Agergaard, K, Mau-Sørensen, M, Stage, T B, Jørgensen, T L, Hassel, R E, Dahl Steffensen, K, Pedersen, J W, Milo, M L H, Poulsen, S H, Pottegård, A, Hallas, J, Brøsen, K & Bergmann, T K 2017, ' Clopidogrel paclitaxel drug-drug interaction : A pharmacoepidemiologic study ', Clinical Pharmacology and Therapeutics, vol. 102, no. 3, pp. 547–553 . https://doi.org/10.1002/cpt.674
Tytuł :
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
Autorzy :
Reynolds, J V
Preston, S R
O'Neill, B
Baeksgaard, L
Griffin, S M
Mariette, C
Cuffe, S
Cunningham, M
Crosby, T
Parker, I
Hofland, K
Hanna, G
Svendsen, L B
Donohoe, C L
Muldoon, C
O'Toole, D
Johnson, C
Ravi, N
Jones, G
Corkhill, A K
Illsley, M
Mellor, J
Lee, K
Dib, M
Marchesin, V
Cunnane, M
Scott, K
Lawner, P
Warren, S
O'Reilly, S
O'Dowd, G
Leonard, G
Hennessy, B
Dermott, R Mc
Pokaż więcej
Temat :
Neoadjuvant chemoradiation therapy
Carboplatin/administration & dosage
Neoplasm Recurrence, Local/drug therapy
Paclitaxel/administration & dosage
Research Support, Non-U.S. Gov't
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Adenocarcinoma/drug therapy
Esophageal Neoplasms/drug therapy
Study Protocol
Female
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Esophagogastric Junction/drug effects
Aged
Oesophagogastric junction
Adenocarcinoma
Middle Aged
Neoadjuvant Therapy
Clinical Trial, Phase III
Randomized Controlled Trial
Neoadjuvant chemotherapy
Disease-Free Survival
RC254-282
Journal Article
Multicenter Study
Adult
Quality of Life
Oesophageal
Humans
Male
Źródło :
Reynolds, J V, Preston, S R, O'Neill, B, Baeksgaard, L, Griffin, S M, Mariette, C, Cuffe, S, Cunningham, M, Crosby, T, Parker, I, Hofland, K, Hanna, G, Svendsen, L B, Donohoe, C L, Muldoon, C, O'Toole, D, Johnson, C, Ravi, N, Jones, G, Corkhill, A K, Illsley, M, Mellor, J, Lee, K, Dib, M, Marchesin, V, Cunnane, M, Scott, K, Lawner, P, Warren, S, O'Reilly, S, O'Dowd, G, Leonard, G, Hennessy, B & Dermott, R M 2017, ' ICORG 10-14 : NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) ', B M C Cancer, vol. 17, 401 . https://doi.org/10.1186/s12885-017-3386-2
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Opis pliku :
application/pdf; text
Tytuł :
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer
Autorzy :
Joerger, Markus
Ess, Silvia
Dehler, Silvia
Savidan, Anita
Bouchardy Magnin, Christine
Frick, Harald
Konzelmann, Isabelle
Thürlimann, Beat
Pokaż więcej
Temat :
Fluorouracil/administration & dosage/analogs & derivatives
Carboplatin/administration & dosage
Neoplasm Staging
610 Medicine & health
Medication Adherence
Odds Ratio
Epirubicin/administration & dosage
Multivariate Analysis
Paclitaxel/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage/therapeutic use
Bridged Compounds/administration & dosage
Deoxycytidine/administration & dosage/analogs & derivatives
Methotrexate/administration & dosage
Cyclophosphamide/administration & dosage
Epidemiology, Biostatistics and Prevention Institute (EBPI)
Female
Logistic Models
ddc:613
Switzerland
Health Services Accessibility
Middle Aged
Vinblastine/administration & dosage/analogs & derivatives
Doxorubicin/administration & dosage
Breast Neoplasms/drug therapy/metabolism/pathology
Receptors, Estrogen/metabolism
Anthracyclines/administration & dosage
Confidence Intervals
Taxoids/administration & dosage
Humans
Lymphatic Metastasis
Źródło :
Joerger, Markus; Ess, Silvia; Dehler, Silvia; Savidan, Anita; Bouchardy, Christine; Frick, Harald; Konzelmann, Isabelle; Thürlimann, Beat (2012). A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer. Swiss Medical Weekly, 142:w13571.
Swiss Medical Weekly, Vol. 142 (2012) P. w13571
Opis pliku :
application/pdf

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies